FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,723,372 | +17.5% | 362,053 | +40.7% | 0.06% | +6.6% |
| Q1 2023 | $1,467,180 | +55.5% | 257,400 | +175.3% | 0.06% | +22.0% |
| Q4 2022 | $943,304 | -53.5% | 93,489 | +3.3% | 0.05% | -36.7% |
| Q3 2022 | $2,028,000 | -11.2% | 90,510 | -1.7% | 0.08% | -20.2% |
| Q2 2022 | $2,283,000 | +25.2% | 92,120 | +95.9% | 0.10% | +25.3% |
| Q1 2022 | $1,824,000 | +2.2% | 47,018 | +56.1% | 0.08% | -38.8% |
| Q3 2021 | $1,785,000 | – | 30,121 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |